 |
Top 10 Multiple Sclerosis startups
Updated: May 01, 2024 | Editor: Jason Kwon |
These startups develop new Multiple Sclerosis treatments and diagnostics technologies, like AI-powered drug-discovery, gene therapy, stem cells, robotics and virtual reality systems for rehabilitation.
1
Country: USA | Funding: $526.3M
Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.
Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.
2
Country: USA | Funding: $499.8M
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, multiple sclerosis (MS).
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, multiple sclerosis (MS).
3
Country: USA | Funding: $409M
Pear Therapeutics develops digital therapies to address a broad range of severe conditions including addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and sleep. PEAR’s eFormulationTM platform combines pharmaceutical preparations with user-friendly, customizable, and scientifically validated software applications. PEAR’s patented approach provides better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payors. Pear Therapeutics filed for bankruptcy
Pear Therapeutics develops digital therapies to address a broad range of severe conditions including addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and sleep. PEAR’s eFormulationTM platform combines pharmaceutical preparations with user-friendly, customizable, and scientifically validated software applications. PEAR’s patented approach provides better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payors. Pear Therapeutics filed for bankruptcy
4
Country: Israel | Funding: $210.6M
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again. Our mission is to fundamentally change the Quality of Life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
ReWalk Robotics is an innovative medical device company that is designing, developing and commercializing exoskeletons allowing wheelchair-bound individuals to stand and walk once again. Our mission is to fundamentally change the Quality of Life for individuals with lower limb disability through the creation and development of market leading robotic technologies.
5
Country: USA | Funding: $183M
Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class that advances programs in multiple sclerosis and psoriasis
Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class that advances programs in multiple sclerosis and psoriasis
6
Country: USA | Funding: $135.5M
The Cour particle platforms provide a novel and highly specific immune targeting capability which may be safely applied to severe inflammatory modulation, and immune (antigen) tolerization.
The Cour particle platforms provide a novel and highly specific immune targeting capability which may be safely applied to severe inflammatory modulation, and immune (antigen) tolerization.
7
Country: USA | Funding: $91M
Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.
Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.
8
Country: USA | Funding: $70M
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
9
Country: Switzerland | Funding: $54.6M
GeNeuro develops innovative treatments against inflammatory and degenerative disorders associated with endogenous retroviruses.
GeNeuro develops innovative treatments against inflammatory and degenerative disorders associated with endogenous retroviruses.
10
Country: USA | Funding: $10.5M
AxoSim's Nerve-on-a-Chip platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
AxoSim's Nerve-on-a-Chip platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
11
Country: Spain | Funding: €5.1M
Bionure Farma develops innovative therapies for the treatment of orphan ophthalmology diseases and multiple sclerosis.
Bionure Farma develops innovative therapies for the treatment of orphan ophthalmology diseases and multiple sclerosis.
12
Country: Switzerland | Funding: 3
ReHaptix is a clinically validated mHealth application assisting patients and healthcare professionals in monitoring the rehabilitation progress of patients suffering from upper limb impairments caused by a neurological injury, such as stroke, multiple sclerosis or Parkinson's disease.
ReHaptix is a clinically validated mHealth application assisting patients and healthcare professionals in monitoring the rehabilitation progress of patients suffering from upper limb impairments caused by a neurological injury, such as stroke, multiple sclerosis or Parkinson's disease.
13
Country: India
Neuro Vigor has found a new use for a long-approved hypertension drug-treating neurodegenerative disease like neuropathies, Parkinson’s, and multiple sclerosis.
Neuro Vigor has found a new use for a long-approved hypertension drug-treating neurodegenerative disease like neuropathies, Parkinson’s, and multiple sclerosis.
14
Country: Israel
InnVentis is a pharmaceutical company that uses big data and machine learning aiming at providing services that could speed up drug development, and creating an ecosystem for Arthritis management. Long term, this platform could extend to other inflammatory conditions, such as asthma and multiple sclerosis.
InnVentis is a pharmaceutical company that uses big data and machine learning aiming at providing services that could speed up drug development, and creating an ecosystem for Arthritis management. Long term, this platform could extend to other inflammatory conditions, such as asthma and multiple sclerosis.
15
Country: USA
Oscine Therapeutics is harnessing the power of stem cell science to revolutionize treatment of CNS diseases
Oscine Therapeutics is harnessing the power of stem cell science to revolutionize treatment of CNS diseases
16
Country: USA
BeCare Link connects patients to physicians and researchers, through the use of a user-friendly mobile app, to provide unprecedented levels of insight about MS and other neurodegenerative diseases.
BeCare Link connects patients to physicians and researchers, through the use of a user-friendly mobile app, to provide unprecedented levels of insight about MS and other neurodegenerative diseases.
17
Country: Russia
Innovative startup for the analysis and diagnosis of multiple sclerosis. Provides cloud service for analyzing MS lesions powered by artificial intelligence
Innovative startup for the analysis and diagnosis of multiple sclerosis. Provides cloud service for analyzing MS lesions powered by artificial intelligence
